Clarus Lifesciences III L.P. 13D and 13G filings for Imago BioSciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-12 4:31 pm Sale |
2023-01-11 | 13D | Imago BioSciences, Inc. IMGO |
Clarus Lifesciences III L.P. | 0 0.000% |
-2,436,732 (Position Closed) |
Filing |
| 2022-04-01 5:18 pm Sale |
2022-03-30 | 13D | Imago BioSciences, Inc. IMGO |
Clarus Lifesciences III L.P. | 2,436,732 7.200% |
-938,305 (-27.80%) |
Filing |
| 2021-07-30 4:32 pm Purchase |
2021-07-20 | 13D | Imago BioSciences, Inc. IMGO |
Clarus Lifesciences III L.P. | 3,375,037 10.500% |
3,375,037 (New Position) |
Filing |